Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
VHH EV
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EEE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
aRBD-2-5
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
S309
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022
VHH W
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH V
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH U
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH E
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
Ferritin-NP-RBD
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/12/2021
NBP11
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
LSNME/SW1
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/01/2021
1-{3-[2-Hydroxy-3-(4-methylpiperidino)propoxy]phenoxy}-3-(4-methylpiperidino)-2-propanol
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
NBP10
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
VH-Fc ab8
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021
2-{3-[3-Chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/22/2021
ABP18
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
gp96-Ig-S
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/26/2021
N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
mAb 58
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022